These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20408734)

  • 1. Magnetic resonance imaging-guided delivery of adeno-associated virus type 2 to the primate brain for the treatment of lysosomal storage disorders.
    Salegio EA; Kells AP; Richardson RM; Hadaczek P; Forsayeth J; Bringas J; Sardi SP; Passini MA; Shihabuddin LS; Cheng SH; Fiandaca MS; Bankiewicz KS
    Hum Gene Ther; 2010 Sep; 21(9):1093-103. PubMed ID: 20408734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety study of adeno-associated virus serotype 2-mediated human acid sphingomyelinase expression in the nonhuman primate brain.
    Salegio EA; Samaranch L; Jenkins RW; Clarke CJ; Lamarre C; Beyer J; Kells AP; Bringas J; Sebastian WS; Richardson RM; Rosenbluth KH; Hannun YA; Bankiewicz KS; Forsayeth J
    Hum Gene Ther; 2012 Aug; 23(8):891-902. PubMed ID: 22574943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adeno-associated viral vector serotype 9-based gene therapy for Niemann-Pick disease type A.
    Samaranch L; Pérez-Cañamás A; Soto-Huelin B; Sudhakar V; Jurado-Arjona J; Hadaczek P; Ávila J; Bringas JR; Casas J; Chen H; He X; Schuchman EH; Cheng SH; Forsayeth J; Bankiewicz KS; Ledesma MD
    Sci Transl Med; 2019 Aug; 11(506):. PubMed ID: 31434754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Merits of combination cortical, subcortical, and cerebellar injections for the treatment of Niemann-Pick disease type A.
    Bu J; Ashe KM; Bringas J; Marshall J; Dodge JC; Cabrera-Salazar MA; Forsayeth J; Schuchman EH; Bankiewicz KS; Cheng SH; Shihabuddin LS; Passini MA
    Mol Ther; 2012 Oct; 20(10):1893-901. PubMed ID: 22828503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease.
    Dodge JC; Clarke J; Song A; Bu J; Yang W; Taksir TV; Griffiths D; Zhao MA; Schuchman EH; Cheng SH; O'Riordan CR; Shihabuddin LS; Passini MA; Stewart GR
    Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17822-7. PubMed ID: 16301517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAV vector-mediated correction of brain pathology in a mouse model of Niemann-Pick A disease.
    Passini MA; Macauley SL; Huff MR; Taksir TV; Bu J; Wu IH; Piepenhagen PA; Dodge JC; Shihabuddin LS; O'Riordan CR; Schuchman EH; Stewart GR
    Mol Ther; 2005 May; 11(5):754-62. PubMed ID: 15851014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain.
    Fu H; Muenzer J; Samulski RJ; Breese G; Sifford J; Zeng X; McCarty DM
    Mol Ther; 2003 Dec; 8(6):911-7. PubMed ID: 14664793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive Transduction and Enhanced Spread of a Modified AAV2 Capsid in the Non-human Primate CNS.
    Naidoo J; Stanek LM; Ohno K; Trewman S; Samaranch L; Hadaczek P; O'Riordan C; Sullivan J; San Sebastian W; Bringas JR; Snieckus C; Mahmoodi A; Mahmoodi A; Forsayeth J; Bankiewicz KS; Shihabuddin LS
    Mol Ther; 2018 Oct; 26(10):2418-2430. PubMed ID: 30057240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow AAV2 clearance from the brain of nonhuman primates and anti-capsid immune response.
    Samaranch L; Hadaczek P; Kells AP; Bringas JR; Stockinger D; San Sebastian W; Macayan M; Samineni S; Pivirotto P; Forsayeth J; Bankiewicz KS
    Gene Ther; 2016 Apr; 23(4):393-8. PubMed ID: 26510688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectors.
    Liu G; Martins I; Wemmie JA; Chiorini JA; Davidson BL
    J Neurosci; 2005 Oct; 25(41):9321-7. PubMed ID: 16221840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination brain and systemic injections of AAV provide maximal functional and survival benefits in the Niemann-Pick mouse.
    Passini MA; Bu J; Fidler JA; Ziegler RJ; Foley JW; Dodge JC; Yang WW; Clarke J; Taksir TV; Griffiths DA; Zhao MA; O'Riordan CR; Schuchman EH; Shihabuddin LS; Cheng SH
    Proc Natl Acad Sci U S A; 2007 May; 104(22):9505-10. PubMed ID: 17517638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.
    Liguore WA; Domire JS; Button D; Wang Y; Dufour BD; Srinivasan S; McBride JL
    Mol Ther; 2019 Nov; 27(11):2018-2037. PubMed ID: 31420242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Widespread optogenetic expression in macaque cortex obtained with MR-guided, convection enhanced delivery (CED) of AAV vector to the thalamus.
    Yazdan-Shahmorad A; Tian N; Kharazia V; Samaranch L; Kells A; Bringas J; He J; Bankiewicz K; Sabes PN
    J Neurosci Methods; 2018 Jan; 293():347-358. PubMed ID: 29042259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain.
    Samaranch L; Blits B; San Sebastian W; Hadaczek P; Bringas J; Sudhakar V; Macayan M; Pivirotto PJ; Petry H; Bankiewicz KS
    Gene Ther; 2017 Apr; 24(4):253-261. PubMed ID: 28300083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracerebral transplantation of adult mouse neural progenitor cells into the Niemann-Pick-A mouse leads to a marked decrease in lysosomal storage pathology.
    Shihabuddin LS; Numan S; Huff MR; Dodge JC; Clarke J; Macauley SL; Yang W; Taksir TV; Parsons G; Passini MA; Gage FH; Stewart GR
    J Neurosci; 2004 Nov; 24(47):10642-51. PubMed ID: 15564580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global CNS correction in a large brain model of human alpha-mannosidosis by intravascular gene therapy.
    Yoon SY; Hunter JE; Chawla S; Clarke DL; Molony C; O'Donnell PA; Bagel JH; Kumar M; Poptani H; Vite CH; Wolfe JH
    Brain; 2020 Jul; 143(7):2058-2072. PubMed ID: 32671406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection.
    Hammond SL; Leek AN; Richman EH; Tjalkens RB
    PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain.
    Hadaczek P; Kohutnicka M; Krauze MT; Bringas J; Pivirotto P; Cunningham J; Bankiewicz K
    Hum Gene Ther; 2006 Mar; 17(3):291-302. PubMed ID: 16544978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann-Pick A disease.
    Dodge JC; Clarke J; Treleaven CM; Taksir TV; Griffiths DA; Yang W; Fidler JA; Passini MA; Karey KP; Schuchman EH; Cheng SH; Shihabuddin LS
    Exp Neurol; 2009 Feb; 215(2):349-57. PubMed ID: 19059399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Safe and Reliable Technique for CNS Delivery of AAV Vectors in the Cisterna Magna.
    Taghian T; Marosfoi MG; Puri AS; Cataltepe OI; King RM; Diffie EB; Maguire AS; Martin DR; Fernau D; Batista AR; Kuchel T; Christou C; Perumal R; Chandra S; Gamlin PD; Bertrand SG; Flotte TR; McKenna-Yasek D; Tai PWL; Aronin N; Gounis MJ; Sena-Esteves M; Gray-Edwards HL
    Mol Ther; 2020 Feb; 28(2):411-421. PubMed ID: 31813800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.